PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 15, 2026In Silico Research in BiomedicineOpen Access

In silico evaluation of the anti-breast cancer potentials of phytochemicals as Estrogen Receptor alpha (ER-α) inhibitors: Virtual screening and molecular dynamics approach

View Full Paper
Ask AI
Bookmark
Share

Authors

MEMaida EngelsKNK NarayanasamySKS Kalpana

Discussion

Loading...

Member takes

Overview

Virtual screening identifies potential anti-breast cancer phytochemicals targeting ER-α, implying new treatment avenues.

Key Points

  • This study aims to evaluate the anti-breast cancer potential of phytochemicals as Estrogen Receptor alpha (ER-α) inhibitors using in silico methods.
  • Utilized the Saudi Anti-human Cancer Plant Database for phytochemical data.
  • Conducted virtual screening of phytochemicals for ER-α inhibition.
  • Performed molecular docking studies with Glide using the Schrodinger interface.
  • Executed molecular dynamics simulations using Desmond.
  • Identified key phytochemicals with docking scores ranging from -10.4 to -9.9 kcal/mol.
  • Phytochemicals like rosmarinic acid, quercetin, and kaempferol showed interaction with critical ER-α residues.
  • Virtual screening provided insights for developing novel ER-α antagonists for breast cancer treatment.

Cite This Study

Engels et al. (2026) studied this question.

synapsesocial.com/papers/69b64c67b42794e3e660db65https://doi.org/10.1016/j.insi.2026.100289
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In Silico Studies of Phytoconstituents to Identify Potential Inhibitors for ERα Protein of Breast Cancer2024
  2. 2Identification of Novel Inhibitors for ERα Target of Breast Cancer By In Silico Approach2024 · 1 citations
  3. 3Phytochemicals for Breast Cancer Therapeutic Intervention: Exploratory In-Silico Molecular Docking Study2024 · 10 citations
  4. 4Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: A structural approach2024 · 1 citations
  5. 5Identifying Potent Breast Cancer Inhibitors Against ERα Target Using Pharmacophore Model, 3D‐QSAR and MD Studies2024